arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Enveric Biosciences, Inc.

ENVB

$1.53 ▼ -0.04 (-2.55%) at close

15 Visible periods

30 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Enveric Biosciences, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap —

Dividend Yield —

Revenue Growth None

Op. Margin None

ROIC -165.9% ↗

FCF / Share $-24.32

Trailing P/E —

Price / Book 0.4x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

15-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$39.91M

↓ -7.2% —

Net Income Profit after all expenses

$-8.77M

↑ +8.4% —

Operating Margin Operating profit as % of sales

-15.8%

↑ +4.7% —

FCF / Share Free cash flow per share

$-24.32

↓ -272.5% —

Long-Term Debt Long-term obligations

$6.45K

↓ -99.7% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Financial Health ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2013 10-K ↗	FY 2014 Dec 31, 2012 10-K ↗	FY 2013 Dec 31, 2011 10-K ↗	FY 2012 Dec 31, 2010 10-K ↗	FY 2011 Dec 31, 2009 10-K ↗
Revenue Growth YoY (%)	—	—	—	—	—	—	-7.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-190%)	-11.5% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-244%)	34.4% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+330%)	—	—	—	—	—	—
EPS Growth YoY (%)	84.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-2724.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	37.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	87.5% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	86.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-9.3% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-257.1% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—
Net Income Growth YoY (%)	8.4% Fair ↓ Fair Declining Year-over-year change in net income	44.6% Excellent ↑ Excellent Improving Year-over-year change in net income	6.4% Fair ↑ Fair Improving Year-over-year change in net income	62.3% Excellent ↑ Excellent Improving Year-over-year change in net income	-613.5% Weak ↓ Weak Declining Year-over-year change in net income	-22.5% Weak ↑ Weak Improving Year-over-year change in net income	66.8% Excellent ↑ Excellent Improving Year-over-year change in net income	-86.2% Weak ↑ Weak Improving Year-over-year change in net income	-226.4% Weak ↑ Weak Improving Year-over-year change in net income	-1727034.2% Weak ↓ Weak Declining Year-over-year change in net income	99.3% Excellent ↑ Excellent Improving Year-over-year change in net income	26.2% Excellent Excellent Year-over-year change in net income	15.4% Good Good Year-over-year change in net income	—	—
FCF Growth YoY (%)	—	—	46.7% Excellent Excellent Year-over-year change in free cash flow	50.3% Excellent Excellent Year-over-year change in free cash flow	—	—	57.3% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	41.0% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	11.6% Fair ↑ Fair Improving Year-over-year change in free cash flow	-11513.7% Weak ↓ Weak Declining Year-over-year change in free cash flow	12.9% Fair ↓ Fair Declining Year-over-year change in free cash flow	42.9% Excellent Excellent Year-over-year change in free cash flow	42.7% Excellent Excellent Year-over-year change in free cash flow	—	—
Revenue CAGR 3Y (%)	—	—	—	—	—	—	3.4% Caution Caution Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2013 10-K ↗	FY 2014 Dec 31, 2012 10-K ↗	FY 2013 Dec 31, 2011 10-K ↗	FY 2012 Dec 31, 2010 10-K ↗	FY 2011 Dec 31, 2009 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	-15.8% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-206%)	-16.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-211%)	-24.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-264%)	-14.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-199%)	—	—	—	—	—
Effective Tax Rate (%) (%)	—	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	7.4% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	13.2% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	-7.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-60.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	20.9% Good Good Actual taxes paid relative to pre-tax income Optimal: 15-25%	57.4% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—
Profit Margin (%) (%)	—	—	—	—	—	—	-14.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-217%)	-39.3% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-427%)	-18.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-256%)	-7.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-164%)	—	—	—	—	—
FCF Margin (%) (%)	—	—	—	—	—	—	-6.1% Weak → Weak Stable Free cash flow as a percentage of revenue Optimal: > 10%	-6.0% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-5.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-7.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—
FCF / Net Income (x)	0.93x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.24x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.57x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.44x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.15x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.30x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	134.36x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.01x Fair → Fair Stable Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.03x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2013 10-K ↗	FY 2014 Dec 31, 2012 10-K ↗	FY 2013 Dec 31, 2011 10-K ↗	FY 2012 Dec 31, 2010 10-K ↗	FY 2011 Dec 31, 2009 10-K ↗
Return on Invested Capital (%)	-165.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-605.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-842.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-172.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-251.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-129.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-64.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-177477.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-503.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-117.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-106.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	89.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-544.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	57.2% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-172.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-312.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-382.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-140.2% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-241.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-137.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-25.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-24.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-22.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-13.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	609.0% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	-405.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-139.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	-3186.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-210.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1500%)	—	—	-125.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-939%)	-219.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1564%)	-201.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1440%)	-52.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-452%)	—	—	—	0.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-95%)	122.7% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+718%)	—	79.7% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+431%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2013 10-K ↗	FY 2014 Dec 31, 2012 10-K ↗	FY 2013 Dec 31, 2011 10-K ↗	FY 2012 Dec 31, 2010 10-K ↗	FY 2011 Dec 31, 2009 10-K ↗
Debt to Equity (x)	—	—	—	—	—	—	0.46x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-23%)	—	—	—	—	—	—	—	—
Interest Coverage (x)	-82777.81x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-5222.92x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-6264.39x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-12.62x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-9.15x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-9.79x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-20.82x Weak Weak Operating income divided by interest expense Optimal: > 5x	-7.16x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—
Net Debt (USD)	—	—	—	—	—	—	$4.45M	$3.84M	$4.80M	$4.06M	$-249.00	$-1.38K	$-18.23K	$-1.13K	$-1.79K
Debt / EBITDA (x)	—	—	—	—	—	—	-0.77x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.73x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.56x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.01x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2013 10-K ↗	FY 2014 Dec 31, 2012 10-K ↗	FY 2013 Dec 31, 2011 10-K ↗	FY 2012 Dec 31, 2010 10-K ↗	FY 2011 Dec 31, 2009 10-K ↗
Revenue per Share (USD)	—	—	—	—	—	—	$18.75	$45.19	$81.08	$69.15	—	—	—	—	—
Basic EPS, GAAP (USD)	$-36.24	$-228.48	$-8.09	$-13.00	$-103.69	—	$-2.83	$-20.50	$-18.75	$-5.25	—	—	—	—	—
Free Cash Flow per Share (USD)	$-24.32	—	$-6.53	$-12.26	$-24.66	—	$-1.15	$-2.70	$-4.57	$-5.17	$-0.04	$-0.05	$-0.09	$-0.16	—
Book Value per Share (USD)	$3.94	—	$0.71	$7.06	$34.22	$0.34	$4.21	—	—	—	$-0.04	$-0.04	$0.01	$-0.19	—
Tangible Book Value per Share (USD)	$3.94	—	$0.64	$6.88	$21.16	$0.16	$-2.65	—	—	—	$-0.04	$-0.04	$0.01	$-0.19	—
Basic Weighted Avg Shares (shares)	334,719	41,908	2.16M	1.45M	472,343	—	2.13M	951,601	599,312	522,744	485,680	485,680	338,537	260,000	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2013 10-K ↗	FY 2014 Dec 31, 2012 10-K ↗	FY 2013 Dec 31, 2011 10-K ↗	FY 2012 Dec 31, 2010 10-K ↗	FY 2011 Dec 31, 2009 10-K ↗
Working Capital (USD)	$4.02M	$1.24M	$1.24M	$14.44M	$15.00M	$1.60M	$-6.78M	$-4.63M	$-15.72M	$-2.64M	$-20.23K	$-20.07K	$4.55K	$-49.52K	—
LT Debt (USD)	—	—	—	—	—	—	—	$6.45K	$1.88M	$1.94M	—	—	—	—	—
Total Equity (USD)	$4.18M	$1.59M	$1.96M	$14.67M	$22.31M	$3.42M	$10.62M	—	—	—	$-20.23K	$-20.07K	$4.55K	$-49.52K	$-10.07K

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2013 10-K ↗	FY 2014 Dec 31, 2012 10-K ↗	FY 2013 Dec 31, 2011 10-K ↗	FY 2012 Dec 31, 2010 10-K ↗	FY 2011 Dec 31, 2009 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	—	—	$39.91M	$43.00M	$48.59M	$36.15M	—	—	—	—	—
Depreciation Expense (USD)	$158.68K	$168.74K	$175.23K	$159.16K	$13.31K	—	—	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-8.77M	$-9.57M	$-17.29M	$-18.47M	$-48.98M	$-6.86M	$-5.60M	$-16.90M	$-9.07M	$-2.78M	$-161.00	$-24.62K	$-33.38K	$-39.44K	—
Operating Cash Flow (USD)	$-8.14M	$-7.73M	$-14.09M	$-17.15M	$-11.46M	$-3.89M	$-2.45M	$-2.57M	$-2.74M	$-2.70M	$-21.63K	$-24.85K	$-30.35K	$-40.67K	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 15 years · 58 quarters

Enveric Biosciences, Inc.

Analytical Summary

15-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ENVB with peers